BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22325155)

  • 1. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
    Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
    Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
    Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; BrĂ´ne B; Mercken M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPA1 antagonists as potential analgesic drugs.
    Andrade EL; Meotti FC; Calixto JB
    Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
    Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of transient receptor potential ankyrin 1 by eugenol.
    Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
    Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
    De Petrocellis L; Schiano Moriello A
    Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.
    Eid SR; Crown ED; Moore EL; Liang HA; Choong KC; Dima S; Henze DA; Kane SA; Urban MO
    Mol Pain; 2008 Oct; 4():48. PubMed ID: 18954467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
    Nassini R; Fusi C; Materazzi S; Coppi E; Tuccinardi T; Marone IM; De Logu F; Preti D; Tonello R; Chiarugi A; Patacchini R; Geppetti P; Benemei S
    Br J Pharmacol; 2015 Jul; 172(13):3397-411. PubMed ID: 25765567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the biology and medicinal chemistry of TRPA1.
    Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
    Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new pyrimidine derivatives with evaluation of their anti-inflammatory and analgesic activities.
    Nofal ZM; Fahmy HH; Zarea ES; El-Eraky W
    Acta Pol Pharm; 2011; 68(4):507-17. PubMed ID: 21796933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRPA1 channel in inflammatory and neuropathic pain and migraine.
    Nassini R; Materazzi S; Benemei S; Geppetti P
    Rev Physiol Biochem Pharmacol; 2014; 167():1-43. PubMed ID: 24668446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.
    Ryckmans T; Aubdool AA; Bodkin JV; Cox P; Brain SD; Dupont T; Fairman E; Hashizume Y; Ishii N; Kato T; Kitching L; Newman J; Omoto K; Rawson D; Strover J
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4857-9. PubMed ID: 21741838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety.
    Shaaban MR; Saleh TS; Mayhoub AS; Mansour A; Farag AM
    Bioorg Med Chem; 2008 Jun; 16(12):6344-52. PubMed ID: 18502132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats.
    Lehto SG; Weyer AD; Youngblood BD; Zhang M; Yin R; Wang W; Teffera Y; Cooke M; Stucky CL; Schenkel L; Geuns-Meyer S; Moyer BD; Wild KD; Gavva NR
    Mol Pain; 2016; 12():. PubMed ID: 27899696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
    Abu-Hashem AA; Gouda MA; Badria FA
    Eur J Med Chem; 2010 May; 45(5):1976-81. PubMed ID: 20149490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological properties of thieno[2',3':4,5]pyrimido [2,1-b][1,3,4]thiadiazine derivatives.
    Santagati A; Modica M; Santagati M; Cutuli V; Amore D; Caruso A
    Farmaco; 1995 Sep; 50(9):605-9. PubMed ID: 7495471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activation.
    Lee KJ; Wang W; Padaki R; Bi V; Plewa CA; Gavva NR
    J Pharmacol Exp Ther; 2014 Aug; 350(2):223-31. PubMed ID: 24893987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
    Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
    J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 4-substituted pyrido[2,3-d]pyrimidin-4(1H)-one as analgesic and anti-inflammatory agents.
    El-Gazzar AR; Hafez HN
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3392-7. PubMed ID: 19481936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
    Rooney L; Vidal A; D'Souza AM; Devereux N; Masick B; Boissel V; West R; Head V; Stringer R; Lao J; Petrus MJ; Patapoutian A; Nash M; Stoakley N; Panesar M; Verkuyl JM; Schumacher AM; Petrassi HM; Tully DC
    J Med Chem; 2014 Jun; 57(12):5129-40. PubMed ID: 24884675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.